<ѻý>Post-AVR Leaflet Thrombosis Often Vanishes Sans Treatmentѻý> Even so, PARTNER 3 substudy found more clinical events with leaflet thickening Sep 27, 2019
<ѻý>Durable-, Bioresorbable-Polymer DES Vie for Short DAPTѻý> Studies explore left main disease, high bleeding risk populations Sep 27, 2019
<ѻý>Patient Data Makes a Slight Dent in Paclitaxel Device Mortality Riskѻý> New meta-analysis still shows risk persists Sep 26, 2019
<ѻý>Dropping Aspirin Early After Stenting Helps High-Risk Patientsѻý> TWILIGHT trial has good news for safety Sep 26, 2019
<ѻý>Could Sapien Valve Weather 25 Years With Little Wear?ѻý> A billion beats in bench testing say yes Sep 26, 2019
<ѻý>TCT: Lab Study Questions Washing Protocols for Bioprosthetic Heart Valvesѻý> Suggests increased leaflet thrombosis risk when storage solutions are rinsed away pre-implant Sep 26, 2018
<ѻý>TCT: Studies Bolster Argument for Protected TAVRѻý> Positive data ahead of CMS reimbursement decision Sep 26, 2018
<ѻý>TCT: Yet More Bad News on Absorb BVSѻý> No advantage in angina and still more risk in further trials Sep 25, 2018
<ѻý>TCT: IVUS Tops Angiography Guidance for Stent Implantationѻý> Intravascular ultrasound-guidance cut TVF in all-comers trial Sep 25, 2018
<ѻý>TCT: Ultrasound Tops RF for Renal Denervationѻý> Head-to-head trial compared techniques for BP effects Sep 25, 2018
<ѻý>TCT: 10 Years On, Surgery for Left Main Disease Edges Stentingѻý> Separate studies suggest some groups do better with CABG Sep 25, 2018
<ѻý>TCT: Near-Infrared Spectroscopy IDs Plaques Likely to Cause Problemsѻý> Non-culprit lesions with large lipid core associated with events Sep 24, 2018
<ѻý>TCT: Stopping Antiplatelets 1 Year Post-Stent Risky for Afib Patients?ѻý> Underpowered trial suggested oral anticoagulation alone isn't enough Sep 24, 2018
<ѻý>TCT: Denervation May Help Some Pulmonary Hypertension Patientsѻý> Pulmonary artery nerve ablation improves outcomes in trial Sep 24, 2018
<ѻý>TCT: TAVR's Prosthesis-Patient Mismatch Problem Gets Airingѻý> It's not just a surgical issue, according to TVT Registry data Sep 24, 2018
<ѻý>TCT: Mitral Valve Device Promising for Milder Functional Casesѻý> Novel transcatheter valve reduced regurgitation versus sham in small trial Sep 24, 2018
<ѻý>TCT: Sapien 3, CoreValve Evolut R on Par for Aortic Stenosisѻý> Head-to-head trial also shows local, general anesthesia outcomes similar Sep 23, 2018
<ѻý>TCT: MitraClip Saves Lives in Functional Mitral Regurgitationѻý> Positive COAPT results may overwrite neutral MITRA-FR findings Sep 23, 2018
<ѻý>TCT: Studies Suggest Thin May Not Always Be in for DESѻý> Resolute Onyx, BioFreedom on par with ultra-thin Orsiro stent Sep 22, 2018
<ѻý>TCT: Femoropopliteal Stents On Par in First Head-to-Head Trialѻý> Primary patency, major adverse events at least as good with Eluvia as Zilver PTX Sep 22, 2018
<ѻý>TCT: Orsiro Stent has Its Day in BIOFLOW V Trialѻý> Does this mean superiority over Xience? Sep 22, 2018
<ѻý>TCT: Spotlight on Novel Heart Techѻý> Polymer valves, leaflet laceration, and more could help solve some persistent problems in valve procedures Sep 22, 2018
<ѻý>TCT: Second Chance for MitraClip in Functional Mitral Regurgitation?ѻý> COAPT takes the spotlight in San Diego Sep 19, 2018
<ѻý>TCT: Stent No Better Than Sham for Stable Angina in ORBITAѻý> No symptom relief beyond placebo effect in first sham-controlled trial Nov 02, 2017
<ѻý>TCT: Are Disappearing-Polymer Metallic DES the Way to Shorter DAPT Duration?ѻý> Trials show good results with two such stents Nov 02, 2017
<ѻý>TCT: 6-Month DAPT OK After STEMI With Modern DESѻý> Non-inferior outcomes versus typical 12-month regimen in DAPT-STEMI Nov 01, 2017
<ѻý>TCT: FDA Reiterates Caution on Absorb Stentѻý> Agency cites ongoing risk at 3-plus years after presumed reabsorption Oct 31, 2017
<ѻý>TCT: Easier Recovery with PCI vs CABG Validated in EXCEL Trialѻý> But early quality of life advantage largely dissipates by 1 year Oct 31, 2017
<ѻý>TCT: Complex Bifurcation Stenting Approach Bests Provisional Stentingѻý> Double kissing crush technique cut target lesion failure and thrombosis Oct 30, 2017
<ѻý>TCT: Multivessel PCI Not Best in Cardiogenic Shockѻý> Trial data show mortality disadvantage versus treating culprit lesions only Oct 30, 2017
<ѻý>TCT: Orsiro No Better Than EES for CTOѻý> Also, injectable collagenase eases PCI for CTO in trial Nov 04, 2016
<ѻý>TCT: Amulet LAA Occluder Hot on the Heels of Watchmanѻý> Another LAA closure device shows favorable results in trial Nov 03, 2016
<ѻý>TCT: Novel Drug-Coated Balloon Promising for Peripheryѻý> Stellarex beat angioplasty alone in fairly complex PAD population trial Nov 03, 2016
<ѻý>Aneurysm Sealing Device Hits Hurdlesѻý> Migration, endoleaks, and aneurysm growth cited for novel Nellix device Nov 02, 2016
<ѻý>TCT: TAVR Holds Up Pretty Well Over Timeѻý> Also, 2-year data confirm lasting improvements in QoL Nov 02, 2016
<ѻý>TCT: For Heart Devices, Will Lag Moving from Europe to U.S. Wane?ѻý> FDA Commissioner and E.U. representative talk change Nov 02, 2016
<ѻý>TCT: Embolic Protection Flops for TAVRѻý> New brain lesions or clinical strokes unaffected in SENTINEL trial Nov 01, 2016
<ѻý>TCT: Trials Split on PCI vs CABG for Left Main Diseaseѻý> NOBLE hands advantage to surgery, EXCEL finds noninferiority Oct 31, 2016
<ѻý>TCT: Advantage of Novel DES Over BMS Grows With Timeѻý> For high bleeding risk patients, rationale for BMS continues to shrink Oct 30, 2016
<ѻý>CardioBrief: Impella No Better Than IABP in Cardiogenic Shockѻý> Underpowered IMPRESS trial shows no mortality benefit Oct 30, 2016